A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 362,153 shares of PFE stock, worth $9.26 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
362,153
Previous 175,395 106.48%
Holding current value
$9.26 Million
Previous $4.91 Million 113.57%
% of portfolio
0.21%
Previous 0.22%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $5.17 Million - $5.86 Million
186,758 Added 106.48%
362,153 $10.5 Million
Q2 2024

Jul 23, 2024

BUY
$25.26 - $29.6 $2.49 Million - $2.92 Million
98,606 Added 128.41%
175,395 $4.91 Million
Q1 2024

Apr 11, 2024

BUY
$25.89 - $29.73 $581,049 - $667,230
22,443 Added 41.3%
76,789 $2.13 Million
Q4 2023

Jan 08, 2024

BUY
$26.13 - $33.94 $753,745 - $979,033
28,846 Added 113.12%
54,346 $1.56 Million
Q3 2023

Oct 06, 2023

BUY
$32.09 - $37.51 $31,127 - $36,384
970 Added 3.95%
25,500 $845,000
Q2 2023

Jul 05, 2023

BUY
$36.12 - $41.79 $18,312 - $21,187
507 Added 2.11%
24,530 $899,000
Q1 2023

Apr 05, 2023

SELL
$39.39 - $51.28 $472 - $615
-12 Reduced 0.05%
24,023 $980,000
Q4 2022

Jan 10, 2023

SELL
$41.75 - $54.5 $10,437 - $13,625
-250 Reduced 1.03%
24,035 $0
Q3 2022

Oct 11, 2022

BUY
$43.76 - $53.42 $76,798 - $93,752
1,755 Added 7.79%
24,285 $1.06 Million
Q2 2022

Jul 06, 2022

BUY
$46.53 - $55.17 $42,249 - $50,094
908 Added 4.2%
22,530 $1.18 Million
Q1 2022

Apr 26, 2022

BUY
$45.75 - $56.69 $31,613 - $39,172
691 Added 3.3%
21,622 $1.12 Million
Q1 2022

Apr 11, 2022

BUY
$45.75 - $56.69 $666,989 - $826,483
14,579 Added 229.52%
20,931 $1.08 Million
Q4 2021

Jan 12, 2022

BUY
$41.32 - $61.25 $330 - $490
8 Added 0.13%
6,352 $375,000
Q3 2021

Oct 07, 2021

BUY
$39.25 - $50.42 $392 - $504
10 Added 0.16%
6,344 $273,000
Q2 2021

Jul 12, 2021

BUY
$35.91 - $40.68 $227,453 - $257,667
6,334 New
6,334 $248,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $144B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Wiley Bros. Aintree Capital, LLC Portfolio

Follow Wiley Bros. Aintree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wiley Bros. Aintree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wiley Bros. Aintree Capital, LLC with notifications on news.